Therapeutic engineering

Tuesday 1 June, 11am

Internal seminar: Eva ROIG ROSELLO (Group Patricia Rousselle) Title to be announced…

Tuesday 11 may, 11am

Internal seminar: Jean-Daniel MALCOR (ROAD group) « Triple-helical peptides in tissue engineering»

Tuesday 25 june, 11am

External seminar: Thomas CROUZIER (KTH Royal Institute of Technology, Stockholm, Invited by C. Monge) « mucines based hydrogels»

The technological innovation from Patricia Rousselle’s laboratory is gaining ground on the wound healing market.

A new molecular signature to better identify radiosensitive patients

A study co-piloted by researchers from the LGRK (IRCM / CEA-Jacob) and the LBTI (Université Claude Bernard Lyon 1) and carried out on cells from patients who developed severe side effects following radiotherapy, enabled the identification of a new molecular signature of the radiosensitivity of healthy tissues. These results, published in Frontiers in Oncology, show

LBTI starts the formulation of promising antiviral drugs against Covid-19 for pulmonary delivery

CovidNanoMed project: “Nanoformulations of current therapeutic drug candidates against SARS-CoV-2 for pulmonary delivery”. ANR Flash Covid-19 – PI: Bernard Verrier https://anr.fr/fr/actualites-de-lanr/details/news/flash-anr-covid-19 The team of B. Verrier, with the help of the group of R. Terreux for bioinformatics and  a partnership with CEA and INRAE, have now started the identification of several promising antiviral candidates among